Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.37 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.37 |
| ▸ | GABRP | O00591 | 2/20 | 0.37 |
| ▸ | GABRD | O14764 | 2/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.37 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.37 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.37 |
| ▸ | GABRE | P78334 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL536369 | 0.88 | LMNA (0.39) | ALDH1A1MEN1KMT2ALMNAESR1 | |
| SCHEMBL1110756 | 0.86 | AMPD2 (0.36) | CYP1A2ALDH1A1MEN1THRBKMT2A | |
| SCHEMBL2230547 | 0.86 | LMNA (0.42) | ALDH1A1MEN1KMT2ALMNAESR1 | |
| SCHEMBL21114063 | 0.84 | TSHR (0.44) | ALDH1A1MEN1KMT2ALMNAESR1 | |
| SCHEMBL27998682 | 0.84 | TSHR (0.44) | ALDH1A1MEN1KMT2ALMNAESR1 | |
| SCHEMBL8682820 | 0.84 | TSHR (0.44) | ALDH1A1MEN1KMT2ALMNAESR1 | |
| SCHEMBL4534219 | 0.84 | TSHR (0.44) | ALDH1A1MEN1KMT2ALMNAESR1 | |
| SCHEMBL17422926 | 0.82 | ALDH1A1 (0.41) | CYP1A2ALDH1A1MEN1THRBKMT2A | |
| Succinic Acid SCHEMBL28849007 | 0.81 | CYP2D6 (0.38) | CYP1A2ALDH1A1MEN1THRBKMT2A | |
| SCHEMBL14672498 | 0.81 | GABRP (0.40) | CYP1A2ALDH1A1MEN1THRBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11186660-B2 | Internal electron donor compound for preparing α-olefin polymerization catalyst component | YINGKOU XIANGYANG CATALYST CO., LTD. | 2021-11-30 | — | — | US | claimed |
| EP-3125879-B1 | PHEROMONE COMPOSITIONS INTENDED FOR TREATING STRESS-RELATED BEHAVIOURAL OR MEDICAL DISORDERS IN NON-HUMAN MAMMALS | CEVA SANTE ANIMALE (FR) | 2020-07-22 | — | — | EP | claimed |
| EP-2652115-B1 | FLUOROPOLYMER COMPOSITIONS | RHODIA CHINA CO LTD (CN) | 2019-10-30 | — | — | EP | claimed |
| US-20190218317-A1 | INTERNAL ELECTRON DONOR COMPOUND FOR PREPARING ALPHA-OLEFIN POLYMERIZATION CATALYST COMPONENT | YINGKOU XIANGYANG CATALYST CO LTD (CN) | 2019-07-18 | — | — | US | claimed |
| EP-3063241-B1 | AN AQUEOUS COATING COMPOSTION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-12-19 | — | — | EP | claimed |
| US-9444084-B2 | Fluoropolymer compositions | SOLVAY (CHINA) CO., LTD. (CN) | 2016-09-13 | — | — | US | claimed |
| EP-2652115-A1 | FLUOROPOLYMER COMPOSITIONS | Rhodia (China) Co., Ltd. (CN) | 2013-10-23 | — | — | EP | claimed |
| US-20130266723-A1 | FLUOROPOLYMER COMPOSITIONS | RHODIA (CHINA) CO., LTD. (CN) | 2013-10-10 | — | — | US | claimed |
| EP-2419476-B1 | FUEL MANAGEMENT SYSTEMS HAVING A FLUORORUBBER ARTICLE IN CONTACT WITH BIODIESEL FUEL | DU PONT (US) | 2013-01-16 | — | — | EP | claimed |
| WO-2012079231-A1 | FLUOROPOLYMER COMPOSITIONS | RHODIA (CHINA) CO., LTD. (CN) | 2012-06-21 | — | — | WO | claimed |
| WO-2012079506-A1 | FLUOROPOLYMER COMPOSITIONS | RHODIA (CHINA) CO., LTD. (CN) | 2012-06-21 | — | — | WO | claimed |
| EP-0084689-B1 | PROCESS FOR THE MANUFACTURE OF A FOUNDRY CORE OR MOULD | AKZO N.V. (NL) | 1985-06-12 | — | — | EP | claimed |
| US-20240359145-A1 | PURIFICATION METHODS COMPRISING THE USE OF MEMBRANES OBTAINED FROM BIO-BASED SULFONE POLYMERS | SOLVAY SPECIALTYPOLYMERS USA LLC (US) | 2024-10-31 | — | — | US | disclosed |
| US-11781014-B2 | Polyamide hot-melt resin granules loaded with active ingredients | AB7 INNOVATION S.A.S.U. | 2023-10-10 | — | — | US | disclosed |
| US-20230174454-A1 | PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE | GENOMATICA, INC. | 2023-06-08 | — | — | US | disclosed |
| EP-4149918-A1 | PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE | Genomatica, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| WO-2005118720-A1 | FLAME RETARDANT POLYURETHANES AND ADDITIVES THEREFOR | ALBEMARLE CORPORATION (US) | 2005-12-15 | — | — | WO | disclosed |
| WO-2005023927-A1 | FLAME RETARDANTS WITH HIGH HALOGEN CONTENT AND LOW VISCOSITY | ALBEMARLE CORPORATION (US) | 2005-03-17 | — | — | WO | disclosed |
| US-20050045857-A1 | Flame retardants with high halogen content and low viscosity | ALBEMARLE CORPORATION | 2005-03-03 | — | — | US | disclosed |
| US-20050045858-A1 | Flame retardants with high halogen content and low viscosity | ALBEMARLE CORPORATION | 2005-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174454-A1 | PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE | CYP8B1, GRHPR, HCAR3 | CYP1A2 744/4885ALDH1A1 967/4885MEN1 3400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.